Free Trial

Rep. Jefferson Shreve Purchases Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background
Remove Ads

Representative Jefferson Shreve (R-Indiana) recently bought shares of Exponent, Inc. NASDAQ: EXPO. In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Exponent stock on February 24th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

  • Purchased $15,001 - $50,000 in shares of RTX NYSE: RTX on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of Royal Gold NASDAQ: RGLD on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of QUALCOMM NASDAQ: QCOM on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 2/24/2025.
  • Sold $15,001 - $50,000 in shares of Norfolk Southern NYSE: NSC on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 2/24/2025.
  • Purchased $50,001 - $100,000 in shares of AbbVie NYSE: ABBV on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of The Cigna Group NYSE: CI on 2/24/2025.
  • Purchased $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 2/24/2025.

Exponent Stock Performance

NASDAQ:EXPO traded up $0.90 during midday trading on Friday, reaching $82.73. 257,578 shares of the stock traded hands, compared to its average volume of 268,408. The stock has a market capitalization of $4.20 billion, a P/E ratio of 39.02 and a beta of 0.77. The company has a fifty day moving average of $88.79 and a 200 day moving average of $97.75. Exponent, Inc. has a 12 month low of $77.27 and a 12 month high of $115.75.

Remove Ads

Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter last year, the company earned $0.41 earnings per share. On average, analysts predict that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Friday, March 7th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.45%. This is an increase from Exponent's previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. Exponent's payout ratio is presently 56.60%.

Insider Activity at Exponent

In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now directly owns 1,800 shares of the company's stock, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.10% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Exponent

Several institutional investors and hedge funds have recently bought and sold shares of EXPO. Westside Investment Management Inc. purchased a new stake in Exponent in the third quarter worth $26,000. Private Trust Co. NA raised its holdings in Exponent by 129.8% in the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after purchasing an additional 157 shares in the last quarter. Atala Financial Inc purchased a new stake in shares of Exponent in the 4th quarter worth about $25,000. Tortoise Investment Management LLC boosted its stake in shares of Exponent by 76.7% during the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after purchasing an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont bought a new stake in shares of Exponent during the 4th quarter valued at about $45,000. Hedge funds and other institutional investors own 92.37% of the company's stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads